__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
On this page, you’ll find some frequently asked questions about KESIMPTA and the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease. Click on the headings below to learn more and reveal the answers to the questions.
Watch Dr Ben Turner explain the pivotal study results for KESIMPTA, including subgroup analysis of newly diagnosed, treatment-naïve patients…
Watch MS Nurse Specialist Emily Whisker discuss the practicalities of initiating KESIMPTA in patients with RMS…
Watch Dr Barry Singer discuss his personal experiences in selecting patients for KESIMPTA…
Watch Dr Ian Pomeroy provide an overview of the prescribing considerations and precautions when using KESIMPTA…
Watch Dr Waqar Rashid discuss the key outcomes from the 4-year KESIMPTA data…
Watch Dr Ian Pomeroy discuss the outcomes of treatment-naïve patients treated with KESIMPTA…
Watch Dr Ben Turner provide an overview of the safety data, including systemic IRRs, from the ASCLEPIOS trials…
IgG, immunoglobulin G; IRR, infusion-related reactions; MS, multiple sclerosis; RMS, relapsing forms of multiple sclerosis.